Amgen’s Megadeal Could Beget Biotech M&A: Bloomberg Deals

December 12, 2022, 7:36 PM UTC

It’s Michelle Davis here in New York. In today’s newsletter, we look at a Merger Monday led by a jumbo health-care deal. Thoma Bravo strikes another software take-private and Microsoft pushes deeper into financial services.

Today’s top stories


  • Thoma Bravo wins auction for Coupa Software.


  • Amgen acquires Horizon Therapeutics for $27.8 billion.


  • Microsoft buying 4% of LSE in cloud deal.


  • Jefferies hires new Italy head from Credit Suisse.

Merger Monday

It’s been an exciting Merger Monday, with Thoma Bravo buying Coupa, Microsoft investing in the London Stock Exchange and a certified megadeal: Amgen agreed to buy Horizon Therapeutics, a maker of rare ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.